Strides Pharma Science Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Strides Pharma Science Ltd. on BSE

Load latest

Strides Pharma Science Ltd.

15 May 2025

887.80

2.02%

Board Meeting

Strides Pharma Science Ltd - 532531 - Board Meeting Intimation for Intimation On Board Meeting

BSE India

Strides Pharma Science Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2025 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of Board of Directors of the Company is scheduled to be held on Thursday, May 22, 2025, inter alia: 1) To consider and approve the audited financial results (standalone and consolidated) of the Company for the quarter and financial year ended March 31, 2025; and 2) To consider and recommend final dividend, if any, on the equity shares of the Company for the financial year ended March 31, 2025. Further, as per the provisions of the Company's Code of Conduct for Prohibition of Insider Trading, trading window for designated persons of the Company has been closed from April 1, 2025 and shall open after 48 hrs post declaration of financial results of the Company.

pdf

Strides Pharma Science Ltd.

10 May 2025

887.80

2.02%

Company Update

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Movement in Senior Management Personnel of the Company.

pdf

Strides Pharma Science Ltd.

30 Apr 2025

887.80

2.02%

Company Update

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Strides strengthens Anti-Inflammatory Portfolio with USFDA approval for Celecoxib Capsules, 100 mg, 200 mg, and 400 mg

pdf

Strides Pharma Science Ltd.

29 Apr 2025

887.80

2.02%

Company Update

Strides Pharma Science Ltd - 532531 - Strides Acquires Identified Andas From Nostrum Laboratories, Inc., USA

BSE India

Strides acquires identified ANDAs from Nostrum Laboratories, Inc., USA

pdf

Strides Pharma Science Ltd.

11 Apr 2025

887.80

2.02%

Company Update

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Acquisition

BSE India

Intimation about incorporation of Step-down Wholly Owned Subsidiary in India.

pdf

Strides Pharma Science Ltd.

03 Apr 2025

887.80

2.02%

Company Update

Strides Pharma Science Ltd - 532531 - Intimation For Change In Details Of Key Managerial Personnel …

BSE India

Intimation for change in details of Key Managerial Personnel for determining materiality of events or information and making disclosure to Stock Exchanges under Regulation 30 of SEBI Listing Regulations effective April 5, 2025

pdf